Back to top
more

Oscar Health (OSCR)

(Delayed Data from NYSE)

$17.65 USD

17.65
3,847,408

+0.85 (5.06%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $17.65 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 250)

Industry: Insurance - Multi line

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Oscar Health, Inc. (OSCR) Stock Moves -1.41%: What You Should Know

by Zacks Equity Research

Oscar Health, Inc. (OSCR) concluded the recent trading session at $16.80, signifying a -1.41% move from its prior day's close.

Oscar Health, Inc. (OSCR) Stock Moves -0.56%: What You Should Know

by Zacks Equity Research

Oscar Health, Inc. (OSCR) concluded the recent trading session at $15.94, signifying a -0.56% move from its prior day's close.

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts

by Zacks Equity Research

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.03, indicating a +0.38% shift from the previous trading day.

AXAHY vs. OSCR: Which Stock Is the Better Value Option?

by Zacks Equity Research

AXAHY vs. OSCR: Which Stock Is the Better Value Option?

Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know

by Zacks Equity Research

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $17.37, representing a -1.19% change from its previous close.

Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts

by Zacks Equity Research

Oscar Health, Inc. (OSCR) concluded the recent trading session at $18.28, signifying a -1.08% move from its prior day's close.

Despite Fast-paced Momentum, Oscar Health (OSCR) Is Still a Bargain Stock

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Oscar Health (OSCR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

AXAHY or OSCR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AXAHY vs. OSCR: Which Stock Is the Better Value Option?

Is Oscar Health (OSCR) a Buy as Wall Street Analysts Look Optimistic?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Oscar Health (OSCR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $21.21, denoting a +1.05% change from the preceding trading day.

Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know

by Zacks Equity Research

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $22.93, representing a -1.46% change from its previous close.

AXAHY vs. OSCR: Which Stock Is the Better Value Option?

by Zacks Equity Research

AXAHY vs. OSCR: Which Stock Is the Better Value Option?

Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $21, representing a +1.6% change from its previous close.

Strength Seen in Oscar Health (OSCR): Can Its 18.7% Jump Turn into More Strength?

by Zacks Equity Research

Oscar Health (OSCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Brokers Suggest Investing in Oscar Health (OSCR): Read This Before Placing a Bet

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), Oscar Health (OSCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

AIZ or OSCR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AIZ vs. OSCR: Which Stock Is the Better Value Option?

Should You Invest in the SPDR S&P Insurance ETF (KIE)?

by Zacks Equity Research

Sector ETF report for KIE

AIZ vs. OSCR: Which Stock Is the Better Value Option?

by Zacks Equity Research

AIZ vs. OSCR: Which Stock Is the Better Value Option?

Oscar Health, Inc. (OSCR) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Oscar Health (OSCR) delivered earnings and revenue surprises of 25% and 1.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's What to Expect From HCI Group (HCI) in Q2 Earnings

by Zacks Equity Research

HCI Group's (HCI) second-quarter results are likely to benefit from better performances across its business units.

Is a Beat in Store for Oscar Health (OSCR) in Q2 Earnings?

by Zacks Equity Research

Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.

Here's What to Expect From Assurant (AIZ) in Q2 Earnings

by Zacks Equity Research

Assurant's (AIZ) Q2 results are likely to reflect higher yields and assets in fixed maturity securities, lower catastrophe reinsurance premiums, higher premium rates and growth in Connected Living.

Sanghamitra Saha headshot

ETFs & Stocks in Focus on Kamala Harris' Shift in Strategy

by Sanghamitra Saha

Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.

Prudential (PRU) Misses Q2 Earnings Estimates

by Zacks Equity Research

Prudential (PRU) delivered earnings and revenue surprises of -1.17% and 0.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Enact Holdings (ACT) delivered earnings and revenue surprises of 23.30% and 2.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?